JPMorgan names top European bank stocks to own heading into 2026

JPMorgan analyst Kian Abouhossein identifies Barclays, UBS and NatWest as preferred European bank stocks heading into 2026, arguing they offer compelling value, disciplined cost control and robust profitability despite macro uncertainty and uneven sector M&A. He highlights Barclays’ cheap valuation (around 7x earnings versus Goldman at 15x) and 2.16% yield, UBS’s tight cost growth (2–3% versus 5–10% for US peers) and 2.47% yield alongside a strong investment‑banking franchise, and NatWest’s UK retail focus delivering ~18% returns on equity and a 4.26% yield. Collectively, JPMorgan views these names as reliable dividend and shareholder‑value plays relative to pricier Swedish banks and other overvalued European peers.

Analysis

JPMorgan senior analyst Kian Abouhossein identifies Barclays, UBS and NatWest as preferred European bank stocks heading into 2026, arguing they combine attractive valuations, disciplined cost control and robust profitability despite macroeconomic uncertainty and uneven M&A activity. The call explicitly contrasts Barclays at ~7x earnings versus Goldman Sachs at ~15x, and flags Swedish banks as less attractive due to high premiums and limited growth.

Abouhossein highlights bank-specific strengths: Barclays offers a deep valuation discount and a 2.16% dividend yield following operational cleanup and improved operating leverage; UBS shows contained cost growth of 2–3% (versus 5–10% for US peers), a competitive investment‑banking franchise and a 2.47% yield; NatWest is positioned as a UK retail play delivering ~18% returns on equity with a 4.26% yield and a strong capital base.

Implications are threefold: these names are presented as dividend‑plus value plays with potential for re‑rating if earnings and cost discipline persist, key monitoring points are earnings multiples, cost‑growth trends, ROE and capital ratios, and primary risks remain UK macro weakness, sector M&A uncertainty and dividend sustainability under stress. Sentiment from the note is moderately positive with modest near‑term market impact.

Key Decisions for Investors

• Consider a modest overweight in Barclays to capture valuation upside and 2.16% yield but size positions prudently and monitor UK macro indicators, CET1 and any signs of earnings disappointment
• Add or trim to UBS on dips to gain exposure to disciplined cost control and investment‑banking upside, watching quarterly cost‑growth metrics (target 2–3%) and IB revenue trends as re‑rating catalysts
• Accumulate or hold NatWest for stable cash returns and high (~18%) ROE with a 4.26% yield while hedging or limiting exposure to UK systemic/regulatory risks and monitoring dividend coverage and capital adequacy